University of Maryland, Baltimore
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Maryland, Baltimore sits in the top decile of US sponsors by registered trial count (#62 of 15,742 sponsors by registered trial count).
University of Maryland, Baltimore: 560 sponsored US clinical trials, 103 recruiting.
University of Maryland, Baltimore sponsors 560 registered US clinical trials on ClinicalTrials.gov, 103 of them currently recruiting, and 332 completed. 77 of these trials are in Phase 3-4 (later-stage) and 161 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Schizophrenia, with 14 trials.
Top-decile sponsor footprint
University of Maryland, Baltimore ranks in the top decile of sponsors by registered trial count (#62 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
332 of 410 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
560 total, page 1 of 12
Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
NCT04401982
Assessment of Treatment Variability for Pelvic Ring Fragility Fractures
NCT07351123
Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis
NCT06864936
GCC 2546- Motion Management
NCT07398209
Pre-Incision Peripheral Nerve Blocks for Lower Extremity Fracture Surgery in Older Adults
NCT07217626
Ketamine for Opioid Use Disorder
NCT06943859
TMS for Inhibition Enhancement in Schizophrenia
NCT06155682
Hub-Based Engagement Navigator Service to Reduce CSC Disengagement
NCT06583239
UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial
NCT06779617
Preserving Ability Through Virtual Exercise (PAVE)
NCT07189286
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
NCT06918977
Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
NCT07032545
Assessment of Fall Risks and Subject-specific Training for Fall Reduction
NCT06396650
A Split-Mouth Clinical Trial Evaluating the Bond Failure Rate of a New Etch-Free Orthodontic Adhesive
NCT07091422
Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
NCT07075510
TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
NCT04843852
RNA Sequencing of Discarded Tracheal Stenosis Tissue to Characterize Cellular and Molecular Pathogenesis
NCT07258784
Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy
NCT06993597
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
NCT06691243
Photobiomodulation and Tooth Analgesia
NCT06691269
Facilitating Neuroplastic Changes of Acute Stroke Survivors
NCT06404268
Ocular Complications From Cancer Therapy - Patient Registry and Biobank
NCT06874283
Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
NCT05977179
A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer
NCT06800339
Placebo Impacts Sleep and Pain Modulation in Chronic Pain
NCT06225817
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
NCT07008664
Client-Centered Care Coordination for Black Men Who Have Sex With Men
NCT06056544
External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting
NCT07053098
Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)
NCT06501781
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
NCT06624839
Vallomix Socket Preservation Study
NCT06472453
White Matter Plasticity in Schizophrenia
NCT06641297
Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
NCT06248216
Older Adults, Methadone, and Cognitive Function
NCT07153029
Diclofenac Dose Response Study
NCT06636227
Enhancing Care & Outcomes for Patients During the First Postpartum Year
NCT06615076
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
NCT06482515
Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
NCT06184126
Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
NCT06546969
Is Physical Therapy Clearance Before Arthroplasty Home Discharge Necessary?
NCT05858086
Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
NCT06154278
Induction of Labor in Morbidly Obese Patients
NCT06199154
HP Pyruvate MRI in Cancers
NCT05697406
MRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD)
NCT06367608
High-Risk Metachronous Oligometastatic Prostate Cancer Trial
NCT06212583
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
NCT06214923
Diaphragm Structure and Function in Children
NCT06230692
Diaphragm Structure and Function in Childhood Cancer Survivors
NCT06205251
Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
NCT06088381
Effect of Zinc on Glucose Homeostasis
NCT05835037
What is open in the University of Maryland, Baltimore pipeline
103 recruiting of 560 indexed (18% open); 332 completed (59%).
Phase mix: 77 late (III/IV) vs 161 early (I/II) (early-phase heavy).
Top condition: Schizophrenia (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Maryland, Baltimore: open-pipeline peers nationwide
Peers matched on 560 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of Maryland, Baltimore sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 560 trials (± recruiting share)
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- Virginia Commonwealth University · 558 trials · 14% recruiting
- National Institute of Neurological Disorders and Stroke (NINDS) · 567 trials · 8% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- Henry Ford Health System · 18% recruiting · 234 trials
- New York Institute of Technology · 18% recruiting · 49 trials
- University of California, San Diego · 18% recruiting · 775 trials
Related
What to do with this University of Maryland, Baltimore page
560 registered trials is a research-attention snapshot, not an endorsement of University of Maryland, Baltimore or any single study.
- 103 of University of Maryland, Baltimore's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Schizophrenia is the condition University of Maryland, Baltimore studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Schizophrenia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Maryland, Baltimore pipeline card: 560 registered trials from official public datasets.Report a data error.